NORTHAMPTONSHIRE

Public Health Northants

Northamptonshire County Council currently commission the following services from Community Pharmacy:· Supervised consumption (through CGL, the Lead provider)· Needle and syringe programme (through CGL, the Lead provider).

Our contacts at CGL are:

Lee Worrall

Community Pharmacist Lead

 

T: 01604 211304

 

Email: lee.worrall@cgl.org.uk

NHS Email: Lee.Worrall@nhs.net

Alison Snelling

Services Manager

(Please note  working days are Monday – Thursday)

 

T: 01604 211304         

Spring House, 39 Billing Road, Northampton, NN1 5BA

· EHC and contraceptive services including provision to supply azithromycin.

PGD178NT Levonorgestrel Community Pharmacist v2.0 (Aug23-Feb26) authorised

PGD109 Azithromycin 2g-Chlamydia (Community Pharmacists) (May22-May24) signed

Pharmacy LES Screening of Chlamydia Specification 2022-24

 

The current sub contractor for NCC is NHFT. Queries should be directed in the first instance to

Lisa Knight-Smith

Sexual Health Outreach Lead
Northamptonshire Healthcare NHS Foundation Trust (NHFT)
Northamptonshire Integrated Sexual Health (NISHH)
Beckett House, 14 Billing Road, Northampton, NN1 5AW

Hotline: 03000 270070

Tel: 03000 270071

Mob: 07563 028 263
lisa.knight-smith@nhft.nhs.uk

NHS Community Pharmacy Extended Care Service Tier 1, 2 and 3

on 15 March 2024, the East Midlands Primary Care Team have notified pharmacies, via email, of the discontinuation in part to the NHS Community Pharmacy Extended Care Service Tier 1, 2 and 3.

The service was reviewed by the East Midlands Pharmacy Governance Group and after careful consideration the group concluded not to offer the service after 31 March 2024. This decision was made due to launch of the Pharmacy First Service which commenced on 31 January 2024, it was recognised that four of the clinical pathways from the extended care Tier 1,2 and 3 services, were to be incorporated and have been aligned to the new advanced pharmacy first services.

There has been further discussion regarding the strategic development and deployment of

  • Acute Bacterial Conjunctivitis 
  • Treatment of Infected Eczema

To support these services, we are required to review and extend the current PGDs, following discussions it has been determined that within the current legal framework this cannot be achieved, in the timeframe to enable extension of the two pathways from 31 March 2024. Therefore, we are suggesting a pause of the two pathways is necessary, until this matter has been resolved and a review will be completed to determine how best to deploy these services across the East Midlands footprint.

Please read below in full the letter from the East Midlands Primary Care Team.

8. Letter to Pharmacies Extended Care Services (002)